Arkansas Children's Hospital is a pediatric hospital with a Level I trauma center in Little Rock, Arkansas. It is among the largest in the United States, serving infants, children, teens, and young adults from birth to age 21.

There are 336 beds in Arkansas Children's Hospital/University of Arkansas for Medical Sciences.

During the past decade, Arkansas Children's Hospital/University of Arkansas for Medical Sciences conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 3 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 1 clinical trials were completed. i.e. 50% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Arkansas Children's Hospital/University of Arkansas for Medical Sciences" #1 sponsor was "Arkansas Children's Hospital Research Institute" with 2 trials, followed by "Ception Therapeutics" with 2 trials sponsored, "Jaeb Center for Health Research" with 2 trials sponsored, "Gilead Sciences" with 1 trials sponsored and "Nventa Biopharmaceuticals Corporation" with 1 trials sponsored. Other sponsors include -3 different institutions and companies that sponsored additional 7 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Arkansas Children's Hospital/University of Arkansas for Medical Sciences" #1 collaborator was "National Eye Institute (NEI)" with 2 trials as a collaborator, "Pediatric Eye Disease Investigator Group" with 2 trials as a collaborator, "Cephalon" with 1 trials as a collaborator, "Duke University" with 1 trials as a collaborator and "Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)" with 1 trials as a collaborator. Other collaborators include 5 different institutions and companies that were collaborators in the rest 15 trials.

According to Clinical.Site data, the most researched conditions in "Arkansas Children's Hospital/University of Arkansas for Medical Sciences" are "Eosinophilic Esophagitis" (2 trials), "Retinopathy of Prematurity" (2 trials), "Acetaminophen Toxicity" (1 trials), "Bronchopulmonary Dysplasia" (1 trials) and "Diabetes Mellitus, Type 1" (1 trials). Many other conditions were trialed in "Arkansas Children's Hospital/University of Arkansas for Medical Sciences" in a lesser frequency.

Most popular intervention types in "Arkansas Children's Hospital/University of Arkansas for Medical Sciences" are "Drug" (5 trials), "Other" (2 trials), "Procedure" (2 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "Bevacizumab" (2 trials), "Furosemide Cohort 1" (1 trials), "Furosemide Cohort 2" (1 trials), "Furosemide Cohort 3" (1 trials) and "IH repair at 55-60 weeks post-menstrual age" (1 trials). Other intervention names were less common.

The vast majority of trials in "Arkansas Children's Hospital/University of Arkansas for Medical Sciences" are 10 trials for "All" genders.

Currently, there are NaN active trials in "Arkansas Children's Hospital/University of Arkansas for Medical Sciences". undefined are not yet recruiting, 2 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 7 completed trials in Arkansas Children's Hospital/University of Arkansas for Medical Sciences, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Arkansas Children's Hospital/University of Arkansas for Medical Sciences, 0 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".